<?xml version="1.0" encoding="UTF-8"?>

<Library xmlns="http://hl7.org/fhir">
  <id value="HIVIND14Logic"/>
  <meta>
    <profile value="http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-shareablelibrary"/>
    <profile value="http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-publishablelibrary"/>
    <profile value="http://hl7.org/fhir/uv/cql/StructureDefinition/cql-library"/>
    <profile value="http://hl7.org/fhir/uv/cql/StructureDefinition/cql-module"/>
  </meta>
  <text>
    <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: Library HIVIND14Logic</b></p><a name="HIVIND14Logic"> </a><a name="hcHIVIND14Logic"> </a><a name="hcHIVIND14Logic-en-US"> </a><h2>Contents</h2><p><code>text/cql</code></p><pre><code class="language-sql">/*
 * Library: HIV.IND.14 Logic
 * Ref No: PRV.14
 * Short Name: OAMT minimum dose
 *
 * Definition: % of OAMT recipients receiving a maintenance dose greater than or equal to the recommended minimum dose
 *
 * Numerator: Number of people, at a specified date, maintained on methadone or buprenorphine receiving recommended minimum maintenance dose (WHO guidance recommends doses of ≥60 mg of methadone or ≥8 mg of buprenorphine*)
 * Numerator Calculation: COUNT of clients with (&quot;Medications prescribed&quot;='Methadone' AND &quot;Dose of medications prescribed&quot; GREATER THAN OR EQUAL TO 60mg) OR (&quot;Medications prescribed&quot;='Buprenorphine' AND &quot;Dose of medications prescribed&quot; GREATER THAN OR EQUAL TO 8mg) for a specified &quot;Reporting date&quot;
 * Numerator Exclusions: &quot;Client being inducted on OAMT&quot; OR &quot;Client on reducing doses of OAMT&quot;
 *
 * Denominator: Number of people receiving maintenance dose of methadone or buprenorphine at a specified date, excluding: a) individuals currently being inducted on OAMT and yet to reach the maintenance dose and b) individuals on reducing doses of OAMT.
 * Denominator Calculation: COUNT of clients with &quot;Medications prescribed&quot; IN 'Methadone', 'Buprenorphine' for a specified &quot;Reporting date&quot;
 * Denominator Exclusions: &quot;Client being inducted on OAMT&quot; OR &quot;Client on reducing doses of OAMT&quot;
 *
 * Disaggregations:
 * • Gender (female, male, other**)
 * • Age (15–19, 20–24, 25–49, 50+ years)
 * • Provider type (key population-led or community-led organization, public sector provider, other entities such as private for-profit and not-for-profit organizations, including faith-based, international, nongovernmental)
 * • Setting: facility-based service (including hospitals, health clinics, general practice offices, etc.) or community-based service (including drop-in centres, community service delivery points, mobile clinics or vans, outreach teams, community support groups, etc.)
 * • Cities and other administrative regions of epidemiologic importance
 * 
 * Disaggregation Elements: Gender | Age
 *
 * Numerator and Denominator Elements:
 * Dose of medications prescribed | Medications prescribed | Reporting date
 *
 * Reference: Consolidated guidelines on person-centred HIV strategic information: strengthening routine data for impact. Geneva: World Health Organization; 2022
 * 
 * Data Concepts:
 *  
 * HIV.A.DE17: Age | Calculated age (number of years) of the client based on date of birth 
 * HIV.A.DE18: Gender* | Gender of the client* 
 * HIV.A.DE19: Female | Client identifies as female 
 * HIV.A.DE20: Male | Client identifies as male 
 * HIV.A.DE21: Transgender male | Client identifies as transgender male 
 * HIV.A.DE22: Transgender female | Client identifies as transgender female 
 * HIV.A.DE23: Other | Additional category 
 * HIV.C.DE75: Medications prescribed | Medications the client was prescribed 
 * HIV.C.DE76: PrEP for HIV prevention | Client was prescribed pre-exposure prophylaxis (PrEP) for HIV prevention 
 * HIV.C.DE77: PEP for HIV prevention | Client was prescribed post-exposure prophylaxis (PEP) for HIV prevention 
 * HIV.C.DE78: Other | Client was prescribed other medications 
 * HIV.D.DE457: Medications prescribed | Name or regimen code of all other medications prescribed during the visit 
 * HIV.D.DE459: Dose of medications prescribed | Number of doses (quantity taken at a single point in time) of drugs prescribed/dispensed 
 * HIV.Config.DE22: Reporting date | Reporting date, for surveys performed on a specific date
 *
 * Additional Context
 * - what it measures: Measures the proportion of OAMT recipients receiving the recommended minimum maintenance dose.
 * - rationale: Evidence demonstrates that maximum benefit from OAMT is gained when individuals receive at least the recommended minimum maintenance dose.
 * - method: Individual-level data obtained from programme records
 * 
 * Suggested Scoring Method: proportion | http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/proportion-measure-cqfm
 */

library HIVIND14Logic

// Included Libraries
using FHIR version '4.0.1'

include HIVIndicatorCommon version '0.0.1' called HIC
include FHIRHelpers version '4.0.1'
include WHOCommon called WCom
include FHIRCommon called FC

// Indicator Definition
</code></pre><p><code>No Content</code> (<code>application/elm+xml</code>)</p></div>
  </text>
  <extension url="http://hl7.org/fhir/StructureDefinition/cqf-knowledgeCapability">
    <valueCode value="computable"/>
  </extension>
  <url value="http://smart.who.int/HIV/Library/HIVIND14Logic"/>
  <version value="0.1.0"/>
  <name value="HIVIND14Logic"/>
  <title value="HIV.IND.14 Logic"/>
  <status value="draft"/>
  <experimental value="true"/>
  <type>
    <coding>
      <system value="http://terminology.hl7.org/CodeSystem/library-type"/>
      <code value="logic-library"/>
    </coding>
  </type>
  <date value="2024-07-01T05:12:03+00:00"/>
  <publisher value="WHO"/>
  <contact>
    <name value="WHO"/>
    <telecom>
      <system value="url"/>
      <value value="http://who.int"/>
    </telecom>
  </contact>
  <description value="% of OAMT recipients receiving a maintenance dose greater than or equal to the recommended minimum dose"/>
  <content>
    <contentType value="text/cql"/>
    <data value="LyoKICogTGlicmFyeTogSElWLklORC4xNCBMb2dpYwogKiBSZWYgTm86IFBSVi4xNAogKiBTaG9ydCBOYW1lOiBPQU1UIG1pbmltdW0gZG9zZQogKgogKiBEZWZpbml0aW9uOiAlIG9mIE9BTVQgcmVjaXBpZW50cyByZWNlaXZpbmcgYSBtYWludGVuYW5jZSBkb3NlIGdyZWF0ZXIgdGhhbiBvciBlcXVhbCB0byB0aGUgcmVjb21tZW5kZWQgbWluaW11bSBkb3NlCiAqCiAqIE51bWVyYXRvcjogTnVtYmVyIG9mIHBlb3BsZSwgYXQgYSBzcGVjaWZpZWQgZGF0ZSwgbWFpbnRhaW5lZCBvbiBtZXRoYWRvbmUgb3IgYnVwcmVub3JwaGluZSByZWNlaXZpbmcgcmVjb21tZW5kZWQgbWluaW11bSBtYWludGVuYW5jZSBkb3NlIChXSE8gZ3VpZGFuY2UgcmVjb21tZW5kcyBkb3NlcyBvZiDiiaU2MCBtZyBvZiBtZXRoYWRvbmUgb3Ig4omlOCBtZyBvZiBidXByZW5vcnBoaW5lKikKICogTnVtZXJhdG9yIENhbGN1bGF0aW9uOiBDT1VOVCBvZiBjbGllbnRzIHdpdGggKCJNZWRpY2F0aW9ucyBwcmVzY3JpYmVkIj0nTWV0aGFkb25lJyBBTkQgIkRvc2Ugb2YgbWVkaWNhdGlvbnMgcHJlc2NyaWJlZCIgR1JFQVRFUiBUSEFOIE9SIEVRVUFMIFRPIDYwbWcpIE9SICgiTWVkaWNhdGlvbnMgcHJlc2NyaWJlZCI9J0J1cHJlbm9ycGhpbmUnIEFORCAiRG9zZSBvZiBtZWRpY2F0aW9ucyBwcmVzY3JpYmVkIiBHUkVBVEVSIFRIQU4gT1IgRVFVQUwgVE8gOG1nKSBmb3IgYSBzcGVjaWZpZWQgIlJlcG9ydGluZyBkYXRlIgogKiBOdW1lcmF0b3IgRXhjbHVzaW9uczogIkNsaWVudCBiZWluZyBpbmR1Y3RlZCBvbiBPQU1UIiBPUiAiQ2xpZW50IG9uIHJlZHVjaW5nIGRvc2VzIG9mIE9BTVQiCiAqCiAqIERlbm9taW5hdG9yOiBOdW1iZXIgb2YgcGVvcGxlIHJlY2VpdmluZyBtYWludGVuYW5jZSBkb3NlIG9mIG1ldGhhZG9uZSBvciBidXByZW5vcnBoaW5lIGF0IGEgc3BlY2lmaWVkIGRhdGUsIGV4Y2x1ZGluZzogYSkgaW5kaXZpZHVhbHMgY3VycmVudGx5IGJlaW5nIGluZHVjdGVkIG9uIE9BTVQgYW5kIHlldCB0byByZWFjaCB0aGUgbWFpbnRlbmFuY2UgZG9zZSBhbmQgYikgaW5kaXZpZHVhbHMgb24gcmVkdWNpbmcgZG9zZXMgb2YgT0FNVC4KICogRGVub21pbmF0b3IgQ2FsY3VsYXRpb246IENPVU5UIG9mIGNsaWVudHMgd2l0aCAiTWVkaWNhdGlvbnMgcHJlc2NyaWJlZCIgSU4gJ01ldGhhZG9uZScsICdCdXByZW5vcnBoaW5lJyBmb3IgYSBzcGVjaWZpZWQgIlJlcG9ydGluZyBkYXRlIgogKiBEZW5vbWluYXRvciBFeGNsdXNpb25zOiAiQ2xpZW50IGJlaW5nIGluZHVjdGVkIG9uIE9BTVQiIE9SICJDbGllbnQgb24gcmVkdWNpbmcgZG9zZXMgb2YgT0FNVCIKICoKICogRGlzYWdncmVnYXRpb25zOgogKiDigKIgR2VuZGVyIChmZW1hbGUsIG1hbGUsIG90aGVyKiopCiAqIOKAoiBBZ2UgKDE14oCTMTksIDIw4oCTMjQsIDI14oCTNDksIDUwKyB5ZWFycykKICog4oCiIFByb3ZpZGVyIHR5cGUgKGtleSBwb3B1bGF0aW9uLWxlZCBvciBjb21tdW5pdHktbGVkIG9yZ2FuaXphdGlvbiwgcHVibGljIHNlY3RvciBwcm92aWRlciwgb3RoZXIgZW50aXRpZXMgc3VjaCBhcyBwcml2YXRlIGZvci1wcm9maXQgYW5kIG5vdC1mb3ItcHJvZml0IG9yZ2FuaXphdGlvbnMsIGluY2x1ZGluZyBmYWl0aC1iYXNlZCwgaW50ZXJuYXRpb25hbCwgbm9uZ292ZXJubWVudGFsKQogKiDigKIgU2V0dGluZzogZmFjaWxpdHktYmFzZWQgc2VydmljZSAoaW5jbHVkaW5nIGhvc3BpdGFscywgaGVhbHRoIGNsaW5pY3MsIGdlbmVyYWwgcHJhY3RpY2Ugb2ZmaWNlcywgZXRjLikgb3IgY29tbXVuaXR5LWJhc2VkIHNlcnZpY2UgKGluY2x1ZGluZyBkcm9wLWluIGNlbnRyZXMsIGNvbW11bml0eSBzZXJ2aWNlIGRlbGl2ZXJ5IHBvaW50cywgbW9iaWxlIGNsaW5pY3Mgb3IgdmFucywgb3V0cmVhY2ggdGVhbXMsIGNvbW11bml0eSBzdXBwb3J0IGdyb3VwcywgZXRjLikKICog4oCiwqBDaXRpZXMgYW5kIG90aGVyIGFkbWluaXN0cmF0aXZlIHJlZ2lvbnMgb2YgZXBpZGVtaW9sb2dpYyBpbXBvcnRhbmNlCiAqIAogKiBEaXNhZ2dyZWdhdGlvbiBFbGVtZW50czogR2VuZGVyIHwgQWdlCiAqCiAqIE51bWVyYXRvciBhbmQgRGVub21pbmF0b3IgRWxlbWVudHM6CiAqIERvc2Ugb2YgbWVkaWNhdGlvbnMgcHJlc2NyaWJlZCB8IE1lZGljYXRpb25zIHByZXNjcmliZWQgfCBSZXBvcnRpbmcgZGF0ZQogKgogKiBSZWZlcmVuY2U6IENvbnNvbGlkYXRlZCBndWlkZWxpbmVzIG9uIHBlcnNvbi1jZW50cmVkIEhJViBzdHJhdGVnaWMgaW5mb3JtYXRpb246IHN0cmVuZ3RoZW5pbmcgcm91dGluZSBkYXRhIGZvciBpbXBhY3QuIEdlbmV2YTogV29ybGQgSGVhbHRoIE9yZ2FuaXphdGlvbjsgMjAyMgogKiAKICogRGF0YSBDb25jZXB0czoKICogIAogKiBISVYuQS5ERTE3OiBBZ2UgfCBDYWxjdWxhdGVkIGFnZSAobnVtYmVyIG9mIHllYXJzKSBvZiB0aGUgY2xpZW50IGJhc2VkIG9uIGRhdGUgb2YgYmlydGggCiAqIEhJVi5BLkRFMTg6IEdlbmRlciogfCBHZW5kZXIgb2YgdGhlIGNsaWVudCogCiAqIEhJVi5BLkRFMTk6IEZlbWFsZSB8IENsaWVudCBpZGVudGlmaWVzIGFzIGZlbWFsZSAKICogSElWLkEuREUyMDogTWFsZSB8IENsaWVudCBpZGVudGlmaWVzIGFzIG1hbGUgCiAqIEhJVi5BLkRFMjE6IFRyYW5zZ2VuZGVyIG1hbGUgfCBDbGllbnQgaWRlbnRpZmllcyBhcyB0cmFuc2dlbmRlciBtYWxlIAogKiBISVYuQS5ERTIyOiBUcmFuc2dlbmRlciBmZW1hbGUgfCBDbGllbnQgaWRlbnRpZmllcyBhcyB0cmFuc2dlbmRlciBmZW1hbGUgCiAqIEhJVi5BLkRFMjM6IE90aGVyIHwgQWRkaXRpb25hbCBjYXRlZ29yeSAKICogSElWLkMuREU3NTogTWVkaWNhdGlvbnMgcHJlc2NyaWJlZCB8IE1lZGljYXRpb25zIHRoZSBjbGllbnQgd2FzIHByZXNjcmliZWQgCiAqIEhJVi5DLkRFNzY6IFByRVAgZm9yIEhJViBwcmV2ZW50aW9uIHwgQ2xpZW50IHdhcyBwcmVzY3JpYmVkIHByZS1leHBvc3VyZSBwcm9waHlsYXhpcyAoUHJFUCkgZm9yIEhJViBwcmV2ZW50aW9uIAogKiBISVYuQy5ERTc3OiBQRVAgZm9yIEhJViBwcmV2ZW50aW9uIHwgQ2xpZW50IHdhcyBwcmVzY3JpYmVkIHBvc3QtZXhwb3N1cmUgcHJvcGh5bGF4aXMgKFBFUCkgZm9yIEhJViBwcmV2ZW50aW9uIAogKiBISVYuQy5ERTc4OiBPdGhlciB8IENsaWVudCB3YXMgcHJlc2NyaWJlZCBvdGhlciBtZWRpY2F0aW9ucyAKICogSElWLkQuREU0NTc6IE1lZGljYXRpb25zIHByZXNjcmliZWQgfCBOYW1lIG9yIHJlZ2ltZW4gY29kZSBvZiBhbGwgb3RoZXIgbWVkaWNhdGlvbnMgcHJlc2NyaWJlZCBkdXJpbmcgdGhlIHZpc2l0IAogKiBISVYuRC5ERTQ1OTogRG9zZSBvZiBtZWRpY2F0aW9ucyBwcmVzY3JpYmVkIHwgTnVtYmVyIG9mIGRvc2VzIChxdWFudGl0eSB0YWtlbiBhdCBhIHNpbmdsZSBwb2ludCBpbiB0aW1lKSBvZiBkcnVncyBwcmVzY3JpYmVkL2Rpc3BlbnNlZCAKICogSElWLkNvbmZpZy5ERTIyOiBSZXBvcnRpbmcgZGF0ZSB8IFJlcG9ydGluZyBkYXRlLCBmb3Igc3VydmV5cyBwZXJmb3JtZWQgb24gYSBzcGVjaWZpYyBkYXRlCiAqCiAqIEFkZGl0aW9uYWwgQ29udGV4dAogKiAtIHdoYXQgaXQgbWVhc3VyZXM6IE1lYXN1cmVzIHRoZSBwcm9wb3J0aW9uIG9mIE9BTVQgcmVjaXBpZW50cyByZWNlaXZpbmcgdGhlIHJlY29tbWVuZGVkIG1pbmltdW0gbWFpbnRlbmFuY2UgZG9zZS4KICogLSByYXRpb25hbGU6IEV2aWRlbmNlIGRlbW9uc3RyYXRlcyB0aGF0IG1heGltdW0gYmVuZWZpdCBmcm9tIE9BTVQgaXMgZ2FpbmVkIHdoZW4gaW5kaXZpZHVhbHMgcmVjZWl2ZSBhdCBsZWFzdCB0aGUgcmVjb21tZW5kZWQgbWluaW11bSBtYWludGVuYW5jZSBkb3NlLgogKiAtIG1ldGhvZDogSW5kaXZpZHVhbC1sZXZlbCBkYXRhIG9idGFpbmVkIGZyb20gcHJvZ3JhbW1lIHJlY29yZHMKICogCiAqIFN1Z2dlc3RlZCBTY29yaW5nIE1ldGhvZDogcHJvcG9ydGlvbiB8IGh0dHA6Ly9obDcub3JnL2ZoaXIvdXMvY3FmbWVhc3VyZXMvU3RydWN0dXJlRGVmaW5pdGlvbi9wcm9wb3J0aW9uLW1lYXN1cmUtY3FmbQogKi8KCmxpYnJhcnkgSElWSU5EMTRMb2dpYwoKLy8gSW5jbHVkZWQgTGlicmFyaWVzCnVzaW5nIEZISVIgdmVyc2lvbiAnNC4wLjEnCgppbmNsdWRlIEhJVkluZGljYXRvckNvbW1vbiB2ZXJzaW9uICcwLjAuMScgY2FsbGVkIEhJQwppbmNsdWRlIEZISVJIZWxwZXJzIHZlcnNpb24gJzQuMC4xJwppbmNsdWRlIFdIT0NvbW1vbiBjYWxsZWQgV0NvbQppbmNsdWRlIEZISVJDb21tb24gY2FsbGVkIEZDCgovLyBJbmRpY2F0b3IgRGVmaW5pdGlvbgo="/>
  </content>
  <content>
    <contentType value="application/elm+xml"/>
  </content>
</Library>